FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to gastroenterology, and can be used for diagnosing musculoskeletal manifestations of inflammatory bowel diseases. The presence of immunological markers is determined in the blood: ASCA IgG, ASCA IgA, pANCA, cANCA, calprotectin, Anti GP-2 IgA, Anti GP-2 IgG. With serum calprotectin values of 6 μg/ml and above, ASCA IgG 11-15 U/ml, ASCA IgA 11-15 U/ml, pANCA 1/180 - 1/360, cANCA 1/180 - 1/360 U/ml, Anti GP-2 IgA 33-65 U/ml, Anti GP-2 IgG 223-480 U/ml diagnose musculoskeletal manifestations of inflammatory bowel diseases.
EFFECT: method provides increased efficiency of early diagnosis of musculoskeletal manifestations of inflammatory bowel diseases due to the determination of immunological markers in the blood.
1 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF ASSESSING COMPLIANCE WITH A GLUTEN-FREE DIET IN PATIENTS WITH GLUTEN-SENSITIVE CELIAC DISEASE | 2022 |
|
RU2800820C1 |
| DIAGNOSTIC TECHNIQUE FOR ASYMPTOMATIC CELIAC DISEASE IN ADULTS | 2020 |
|
RU2747523C1 |
| METHOD OF THE TREATMENT OF POLYNEUROPATHY ASSOCIATED WITH GLUTEN-SENSITIVE CELIAC DISEASE | 2022 |
|
RU2800847C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF INFLAMMATORY INTESTINAL CANAL DISEASES IN CHILDREN ACCORDING TO A SET OF CLINICAL, ANAMNESTIC, LABORATORY AND INSTRUMENTAL CRITERIA | 2020 |
|
RU2763258C1 |
| METHOD OF TREATING INFLAMMATORY INTESTINAL DISEASES | 2009 |
|
RU2394571C1 |
| METHOD FOR DIAGNOSING SEVERE PSEUDOMEMBRANOUS COLITIS IN PATIENTS AFTER CORONAVIRUS INFECTION | 2022 |
|
RU2786752C1 |
| METHOD FOR TREATING INFLAMMATORY DISEASES OF TERMINAL COLON | 2022 |
|
RU2807235C1 |
| METHOD OF TREATING AND PREVENTING GASTROINTESTINAL AND OTHER IMMUNODEFICIENT DISEASES WITH CHRONIC INFLAMMATORY SYNDROME | 2018 |
|
RU2708373C2 |
| METHOD FOR SURGICAL TREATMENT OF PATIENTS WITH A STRUCTURING FORM OF CROHN'S DISEASE | 2023 |
|
RU2806298C1 |
| METHOD OF TREATING POSTTRAUMATIC ARTHRALGIC SYNDROME IN CHILDREN | 2018 |
|
RU2709961C1 |
